However, with the aspects of these new mass obesity medications, the microenvironment, the genetic environment, and lifestyle and behavior change is especially difficult for these patients to lose weight and maintain it, and we also know that, from SURMOUNT trials and some real-world evidence, that tirzepatide is extremely effective at encouraging significant weight loss. Huang and colleagues conducted a retrospective cohort study of 4,241 women living with PCOS (median age, 34 years
This is particularly important given that GLP-1 medications often involve dose adjustments, side effect management, shifts in appetite behaviour, and occasional plateaus that benefit from structured clinical reassurance
This could treat conditions like muscle spasms or localized pain
Patients who took Ozempic in a 2021 clinical trial lost nearly 15% of their body weight